Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT
Launched by BENHA UNIVERSITY · Apr 7, 2021
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • confirmed primary NMIBC (Ta, Tis, T1)
- • Age \> 18 years
- Exclusion Criteria:
- • MIBC
- • anterior located mass ( difficult or non visualized)
About Benha University
Benha University, a leading institution in Egypt, is dedicated to advancing medical research and innovation through rigorous clinical trials. With a strong emphasis on multidisciplinary collaboration, the university aims to enhance healthcare outcomes by exploring novel therapeutic approaches and interventions. Its state-of-the-art facilities and commitment to ethical research practices ensure that all trials are conducted with the highest standards of integrity and scientific rigor. Benha University actively contributes to the global medical community by fostering partnerships and disseminating findings that can improve patient care and inform public health policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Banhā, Qalubia, Egypt
Patients applied
Trial Officials
Waleed El-Shaer, M.D
Principal Investigator
Faculty of medicine, Banha university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials